Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Pathway Medical, With FDA Clearance in Hand, Starts Selling Device for Wiping Out Blockages in Leg Arteries
|
Luke Timmerman |
09/05/08 |
|
Seattle
|
|
Alnylam Sees Opportunity in Turning Genes On, And Off
|
Luke Timmerman |
09/05/08 |
|
Boston
|
|
Broad Institute Will Sever Administrative—Not Research—Ties with MIT and Harvard, Becoming “Stand-Alone” Organization
|
Ryan McBride |
09/04/08 |
|
Boston
|
|
Pharmas Flock to Sermo, Biogen Idec Takes Another Tack with MS, $400M More for the Broad Institute, & More Life Sciences News
|
Rebecca Zacks |
09/04/08 |
|
Boston
|
|
The “Augmenix” Question: Can Amar Sawhney Do It Again with Latest Hydrogel Startup?
|
Ryan McBride |
09/04/08 |
|
Boston
|
|
Broad Institute Gets $400M Endowment From Namesakes
|
Ryan McBride |
09/03/08 |
|
Boston
|
|
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA
|
Luke Timmerman |
09/03/08 |
|
Seattle
|
|
Corporate Life Sciences VCs on the Rise in New England—the List
|
Ryan McBride |
09/03/08 |
|
Boston
|
|
Oncothyreon To Sell Stock, Bet Resources on Developing Two Cancer Drugs
|
Luke Timmerman |
09/02/08 |
|
Seattle
|
|
Targanta Antibiotic Shown Effective in Less-Frequent Dose
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Ariad Pharmaceuticals Edging Toward Becoming a Commercial Cancer Drug Company
|
Luke Timmerman |
09/02/08 |
|
Boston
|
|
Boston Scientific Gets Damages Reduced in Patent Case with Medtronic
|
Luke Timmerman |
08/29/08 |
|
Boston
|
|
ZymoGenetics Sells Land for $11.5 Million
|
Luke Timmerman |
08/29/08 |
|
Seattle
|
|
North Shore Biotech Accelerator Wins State Grant
|
Ryan McBride |
08/29/08 |
|
Boston
|
|
Impel NeuroPharma Develops Novel Delivery System to Get Drugs Into the Brain
|
Luke Timmerman |
08/29/08 |
|
Seattle
|
|
SonoSite Marketing Boss Resigns to Take Job at Smith & Nephew
|
Luke Timmerman |
08/28/08 |
|
Seattle
|
|
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections
|
Luke Timmerman |
08/28/08 |
|
Seattle
|
|
Salient Surgical Cuts $86M IPO
|
Ryan McBride |
08/27/08 |
|
Boston
|
|
Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis
|
Luke Timmerman |
08/27/08 |
|
Boston
|
|
UW TechTransfer’s Linden Rhoads Aiming to Nurture More Startups, Entice More VCs to Look at UW’s Research Cupboard
|
Luke Timmerman |
08/27/08 |
|
Seattle
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
|
Boston
|
|
Indevus Pharma Raises $105M in Debt Sale
|
Ryan McBride |
08/26/08 |
|
Boston
|
|
Curis Begins Phase 1 Trial of Anti-Tumor Drug
|
Ryan McBride |
08/26/08 |
|
Boston
|
|
QLT Licenses Atrigel Rights to Reckitt Benckiser
|
Luke Timmerman |
08/26/08 |
|
Seattle
|
|
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling
|
Luke Timmerman |
08/26/08 |
|
Boston
|
|
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors
|
Luke Timmerman |
08/26/08 |
|
Seattle
|
|
Quanterix Collects $15 Million in Series A Venture Round
|
Luke Timmerman |
08/25/08 |
|
Boston
|
|
Cell Therapeutics Authorizes 1-for-10 Reverse Stock Split
|
Luke Timmerman |
08/25/08 |
|
Seattle
|
|
Genzyme, Medicines for Malaria Venture Form Partnership to Develop New Treatments
|
Luke Timmerman |
08/25/08 |
|
Boston
|
|
Announcing Xconomy’s Next Forum: How to Build A Life Sciences Company
|
Robert Buderi |
08/25/08 |
|
Boston
|
|
Page 1 of
10 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
